News

Event: Research and development of new tuberculosis vaccines


9 May 2010
by Working Group

TBVI
TBVI

The University of Zaragoza (Spain), together with TuBerculosis Vaccine Initiative (TBVI) and the Spanish Fundación Ramón Areces, presents an international symposium: “Research and Development of new Tuberculosis Vaccines”.

This symposium will be held on 3 and 4 June in Zaragoza, Spain. During the symposium, the latest developments in new vaccines for TB will be discussed. The symposium includes the European conference under the Spanish presidency 2010 ‘Research and development of European TB vaccines for the world’. The event will join European scientists and researchers, world leaders in the field of research of new vaccines against TB, to present and translate to the scientific community and the society their efforts and the results of the latest European scientific research in the most advanced TB vaccines.

The two day event starts off Thursday (June 3) with a scientific program in which several renowned scientists present the latest on research on new TB vaccines, clinical trials of TB vaccines and research and development of European TB vaccines for the world. Followed on Friday by the European conference where representatives of Spanish ministries and among others the European Centre for Disease Prevention and Control (ECDC), the European Commission and the Bill & Melinda Gates Foundation will speak.

For more information about the program and (free) registration: http://www.tbvi.eu/news-agenda/events/event/international-symposium-on-new-tb-vaccines-zaragoza.html

Event Contact:

Ms. Erna Balk
Director Communications & Advocacy Relations
+31 320 29 32 65
erna.balk(at)wur.nl

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...